Rotavirus Reverse Genetics System to Study Viral Pathogenesis and Receptor Interactions

轮状病毒反向遗传学系统研究病毒发病机制和受体相互作用

基本信息

  • 批准号:
    10739026
  • 负责人:
  • 金额:
    $ 19.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-07-10 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

1 Abstract 2 Rotaviruses (RVs) of group A (RVAs) remain an important cause of acute gastroenteritis and mortality in young animals 3 and children. Despite their significance, mechanisms of RVA cell entry, replication and attenuation remain poorly 4 understood indicating a critical need to address these knowledge gaps and design universal control approaches. 5 We have previously conducted comparative sequence analysis that identified two key amino acid substitutions 6 associated with cell culture adaptation and attenuation: D385N in the VP4 of most human and porcine RVA strains and 7 D393H in porcine OSU strain VP4 only. While these or similar mutations were previously suggested to be important for 8 cell culture adaptation/attenuation, their function has not been confirmed experimentally. Using our porcine intestinal 9 enteroid (PIE) system, we have demonstrated that contrasting modes of interactions with the host glycans determine 10 replication efficacy of different RVA strains. OSU replication was uniquely and significantly down-regulated by the 11 removal of terminal sialic acids, while the latter significantly enhanced the replication of a novel porcine G9P[13] strain. 12 OSU is a historic dominant RVA variant characterized by robust in vivo and in vitro replication and consistently 13 associated with diarrheal disease in piglets for several decades, while G9P[13] and G9P[19] are recent, globally 14 emerging RVA variants in swine and humans. It is possible that the latter strains have evolved to acquire some biological 15 advantage allowing for their efficient spread and replication in different hosts. Virulent OSU and G9P[13] strains have 16 unique aa substitutions in the aa positions 385 and 393 of the VP4 hydrophobic loop, which could be a reason for 17 variable interactions with host glycans. Additionally, our recent study demonstrated that the host (PIE) transcriptome 18 response associated with OSU and G9P[13] infections differed drastically altering glycan expression, cholesterol 19 metabolism and innate immune signaling in a strain-specific manner. These findings suggest that evolutionary 20 adaptation of RVAs to the host and host glycans is a critical mechanism allowing for their interspecies (including 21 zoonotic) transmission. 22 Following a previously optimized protocol, our lab has successfully cloned 11 segments of virulent RVA OSU into the 23 pT7 plasmid and rescued infectious virus. We now propose to use this reverse genetics system for in-depth exploration 24 of the molecular mechanisms of RVA virulence, cell attachment and replication. The specific aims to achieve this goal 25 are summarized below: 26 Aim 1: Evaluate if the D385N and D393H substitutions (individually or in combination with other mutations in the OSU 27 VP4) introduced into OSU RGS (ic-virOSU) will confer an attenuated phenotype to the progeny virus (ic-attOSU). Aim 28 2: Evaluate if G9P[13]-like mutations (S385N and D393N) will confer the G9P[13]-like glycan specificity to the progeny 29 virus (ic-G9OSU). Aim 3: To conduct comparative transcriptome analysis of the wild-type (ic-virOSU) and mutant (OSU- 30 att and OSU-G9) OSU variants. Our PIE and Gn pig models as well as the newly established RGS will allow to study 31 how the identified VP4 mutations alter RVA virulence and the selective interactions with host glycans. 32
1篇摘要 2 A组轮状病毒(RVs)是引起幼龄动物急性胃肠炎和死亡的重要原因 3、孩子尽管它们的意义,RVA细胞进入,复制和衰减的机制仍然很差 4项理解表明迫切需要解决这些知识差距并设计通用控制方法。 5我们之前进行了比较序列分析,确定了两个关键的氨基酸取代 6与细胞培养适应和减毒相关:大多数人和猪RVA毒株的VP 4中的D385 N, 7仅在猪OSU菌株VP 4中的D393 H。虽然这些或类似的突变以前被认为是重要的, 8细胞培养适应/减毒,它们的功能尚未得到实验证实。利用我们的猪肠 9肠(PIE)系统,我们已经证明,与宿主聚糖的相互作用的对比模式决定了 10不同RVA菌株的复制效力。OSU复制是独特的,并显着下调, 11去除末端唾液酸,而后者显著增强了新型猪G9 P菌株的复制[13]。 12 OSU是一种历史性的显性RVA变异体,其特征在于体内和体外复制稳健,并且与RVA变异体一致。 13与仔猪腹泻病相关,而G9 P [13]和G9 P [19]是最近在全球范围内发现的。 猪和人类中出现的14种RVA变异。后一种菌株可能已经进化到获得一些生物学特性, 15个优点,允许它们在不同主机中有效传播和复制。毒力OSU和G9 P [13]菌株具有 在VP 4疏水环的aa位置385和393中存在16个独特的aa取代,这可能是VP 4疏水环的aa位置385和393中存在16个独特的aa取代的原因。 与宿主聚糖的17种可变相互作用。此外,我们最近的研究表明,宿主(PIE)转录组 18与OSU和G9 P感染相关的反应[13]显著不同, 19代谢和先天性免疫信号转导的菌株特异性方式。这些发现表明, RVA对宿主和宿主聚糖的适应是一种关键机制,允许它们的种间(包括 21人畜共患)传播。 22遵循先前优化的方案,我们的实验室成功地将11个强毒RVA OSU片段克隆到 23 pT 7质粒和拯救的感染性病毒。我们现在提议利用这种反向遗传学系统进行深入探索 RVA毒力、细胞附着和复制的分子机制。实现这一目标的具体目标 25项总结如下: 目的1:评估D385 N和D393 H置换(单独地或与OSU中的其他突变组合)是否与D385 N和D393 H置换相关。 27 VP 4)将赋予后代病毒(ic-attOSU)减毒表型。目的 28 2:评估G9 P [13]样突变(S385 N和D393 N)是否将赋予后代G9 P [13]样聚糖特异性 29病毒(ic-G9 OSU)。目的3:对野生型(ic-virOSU)和突变型(OSU-100)进行比较转录组分析。 30 att和OSU-G9)OSU变体。我们的PIE和Gn猪模型以及新建立的RGS将允许研究 31鉴定的VP 4突变如何改变RVA毒力和与宿主聚糖的选择性相互作用。 32

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Linda J. Saif其他文献

Mucosal and systemic isotype-specific antibody responses to bovine coronavirus structural proteins in naturally infected dairy calves.
自然感染的奶牛中对牛冠状病毒结构蛋白的粘膜和全身同种型特异性抗体反应。
Infection and cross-protection studies of winter dysentery and calf diarrhea bovine coronavirus strains in colostrum-deprived and gnotobiotic calves.
初乳剥夺和限生犊牛中冬痢和犊牛腹泻牛冠状病毒株的感染和交叉保护研究。
Rapid, simple method of preparing rotaviral double-stranded ribonucleic acid for analysis by polyacrylamide gel electrophoresis
快速、简单地制备用于聚丙烯酰胺凝胶电泳分析的轮状病毒双链核糖核酸的方法
  • DOI:
    10.1128/jcm.14.3.273-280.1981
  • 发表时间:
    1981
  • 期刊:
  • 影响因子:
    9.4
  • 作者:
    K. Theil;M. Christine;McCLOSKEY;Linda J. Saif;Donald R. Redman;Edward H. Bohl;Dale D. Hancock;Erwin M. Kohler;Philip D. Moorhead
  • 通讯作者:
    Philip D. Moorhead
Nongroup A rotaviruses of humans and animals.
人类和动物的非 A 组轮状病毒。
One Health perspectives on SARS-CoV-2 and other coronavirus threats to humans and animals
关于 SARS-CoV-2 以及其他对人类和动物构成威胁的冠状病毒的“一个健康”观点
  • DOI:
    10.1016/j.onehlt.2024.100788
  • 发表时间:
    2025-06-01
  • 期刊:
  • 影响因子:
    4.500
  • 作者:
    Linda J. Saif
  • 通讯作者:
    Linda J. Saif

Linda J. Saif的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Linda J. Saif', 18)}}的其他基金

Project 2: Serologic and molecular determinants of COVID-19 severity and immune protection
项目 2:COVID-19 严重程度和免疫保护的血清学和分子决定因素
  • 批准号:
    10222411
  • 财政年份:
    2020
  • 资助金额:
    $ 19.69万
  • 项目类别:
Project 2: Serologic and molecular determinants of COVID-19 severity and immune protection
项目 2:COVID-19 严重程度和免疫保护的血清学和分子决定因素
  • 批准号:
    10688394
  • 财政年份:
    2020
  • 资助金额:
    $ 19.69万
  • 项目类别:
The impact of vitamin A on the gut-mammary gland-secretory IgA axis during enteric viral infections
肠道病毒感染期间维生素 A 对肠道-乳腺-分泌 IgA 轴的影响
  • 批准号:
    10427171
  • 财政年份:
    2018
  • 资助金额:
    $ 19.69万
  • 项目类别:
The impact of vitamin A on the gut-mammary gland-secretory IgA axis during enteric viral infections
肠道病毒感染期间维生素 A 对肠道-乳腺-分泌 IgA 轴的影响
  • 批准号:
    9759974
  • 财政年份:
    2018
  • 资助金额:
    $ 19.69万
  • 项目类别:
The impact of vitamin A on the gut-mammary gland-secretory IgA axis during enteric viral infections
肠道病毒感染期间维生素 A 对肠道-乳腺-分泌 IgA 轴的影响
  • 批准号:
    9913564
  • 财政年份:
    2018
  • 资助金额:
    $ 19.69万
  • 项目类别:
Lactogenic immunity/probiotics: Effect on neonatal gut immunity
泌乳免疫/益生菌:对新生儿肠道免疫的影响
  • 批准号:
    7656023
  • 财政年份:
    2009
  • 资助金额:
    $ 19.69万
  • 项目类别:
Vitamin A adjuvant to enhance gut immunity and rotavirus vaccines in neonates
增强新生儿肠道免疫力的维生素 A 佐剂和轮状病毒疫苗
  • 批准号:
    7880605
  • 财政年份:
    2009
  • 资助金额:
    $ 19.69万
  • 项目类别:
Lactogenic immunity/probiotics: Effect on neonatal gut immunity
泌乳免疫/益生菌:对新生儿肠道免疫的影响
  • 批准号:
    7841951
  • 财政年份:
    2009
  • 资助金额:
    $ 19.69万
  • 项目类别:
Vitamin A adjuvant to enhance gut immunity and rotavirus vaccines in neonates
增强新生儿肠道免疫力的维生素 A 佐剂和轮状病毒疫苗
  • 批准号:
    7706606
  • 财政年份:
    2009
  • 资助金额:
    $ 19.69万
  • 项目类别:
Lactogenic immunity/probiotics: Effect on neonatal gut immunity
泌乳免疫/益生菌:对新生儿肠道免疫的影响
  • 批准号:
    8090115
  • 财政年份:
    2009
  • 资助金额:
    $ 19.69万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 19.69万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.69万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 19.69万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.69万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 19.69万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 19.69万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.69万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 19.69万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 19.69万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.69万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了